Complications | All patients (n = 135) | Tranexamic acid (n = 52) | Control (n = 83) | P-value |
---|---|---|---|---|
Major bleeding complications, n (%) | 20 (14.8) | 3 (5.8) | 17 (20.5) | 0.024 |
Reoperationa, n (%) | 8 (5.9) | 0 (0.0) | 8 (9.6) | 0.023 |
RBC transfusiona, n (%) | 15 (11.1) | 2 (3.8) | 13 (15.7) | 0.047 |
Hemothoraxa, n (%) | 1 (0.7) | 0 (0.0) | 1 (1.2) | 1.0 |
Pericardial effusiona, n (%) | 3 (2.2) | 1 (1.9) | 2 (2.4) | 1.0 |
Life-threatening bleeda, n (%) | 1 (0.7) | 0 (0.0) | 1 (1.2) | 1.0 |
Pocket hematoma, n (%) | 26 (19.3) | 4 (7.7) | 22 (26.5) | 0.013 |
Pocket related infection, n (%) | 1 (0.7) | 0 (0.0) | 1 (1.2) | 1.0 |
Pneumothorax, n (%) | 2 (1.4) | 1 (1.9) | 1 (1.2) | 1.0 |